For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Take a look at our BETA site and see what we’ve done so far.
Search and browse selected products
Purchase these through your usual distributor
Apoptosis may be induced in experimental systems through a variety of methods. In general, methods to induce apoptosis can be divided into two categories: biological induction and chemical induction.
Activation of Fas or TNF receptors by their respective ligands, or by cross-linking with an agonist antibody, induces apoptosis of Fas- or TNF receptor-bearing cells. Here we describe a general protocol to induce apoptosis using an anti-Fas receptor (anti-CD95) monoclonal antibody (mAb) in Jurkat cells. The mouse monoclonal anti-Fas antibody [UT-1] (ab11881) can be used for apoptosis indication.
Apoptosis inducers act on several apoptosis-related proteins to promote apoptotic cell death. Depending on the agent selected and the concentrations used, apoptotic events can be detected between 8–72 h post-treatment. However, not all reagents will affect a particular cell line in the same way.
These are general guidelines for inducing cellular damage with chemical agents that will lead to apoptosis.
|Doxorubicin hydrochloride (ab120629)||0.2 µg/mL (25 µg/mL stock|
prepared in H2O)
|Staurosporine (ab120056)||1 µM (1 mM stock prepared in|
|Etoposide (ab120227)||1–10 µM (1 mM stock prepared|
|Camptothecin (ab120115)||2–10 µM (1 mM stock prepared|
|Paclitaxel (ab120143)||50–100 nM (stock prepared in|
|Vinblastine (ab145649)||60 nM (stock prepared in|
|Z-VAD-FMK (ab120382)||50 µM (stock prepared in DMSO)|